Trial intelligence / Profile preview

PROCRIT in Anemic Elderly Patients With Chronic Kidney Disease

NCT00338468Phase 4Terminated

Sponsor
Ortho Biotech Inc.
Start
Nov 2003
Modality
Biologic, rProtein (Recombinant Protein)
01

Overview

A Phase 4 trial of epoetin alfa in anemia, sponsored by Ortho Biotech Inc.. Started Nov 2003; status: terminated.

02

Drugs

epoetin alfa
03

Conditions

anemia

Beyond the preview

Go deeper on NCT00338468.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00338468.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call